Search Results

There are 23379 results for: content related to: Efficacy and safety of venous thromboembolism prophylaxis with fondaparinux or low molecular weight heparin in a large cohort of consecutive patients undergoing major orthopaedic surgery – findings from the ORTHO-TEP registry

  1. Pentasaccharides for the prevention of venous thromboembolism

    Intervention Review

    The Cochrane Library

    Kezhou Dong, Yanzhi Song, Xiaodong Li, Jie Ding, Zhiyong Gao, Daopei Lu and Yimin Zhu

    Published Online : 31 OCT 2016, DOI: 10.1002/14651858.CD005134.pub3

  2. Fondaparinux-associated heparin-induced thrombocytopenia

    European Journal of Haematology

    Volume 91, Issue 5, November 2013, Pages: 437–441, Vijaya R. Bhatt, Madan R. Aryal, Rajesh Shrestha and James O. Armitage

    Version of Record online : 19 AUG 2013, DOI: 10.1111/ejh.12179

  3. Pentasaccharide Derivatives

    Therapeutic Advances in Thrombosis, Second Edition

    Antonio Gutierrez, Pierluigi Tricoci, John H. P. Alexander, Pages: 128–149, 2012

    Published Online : 3 OCT 2012, DOI: 10.1002/9781118410875.ch9

  4. You have free access to this content
    Abstracts

    Journal of Thrombosis and Haemostasis

    Volume 3, Issue s1, August 2005, Pages: P0001–P2386,

    Version of Record online : 9 SEP 2013, DOI: 10.1111/j.1538-7836.2005.0300c.x

  5. You have free access to this content
    Abstracts

    Journal of Thrombosis and Haemostasis

    Volume 3, Issue s1, August 2005, Pages: H01–SYM90,

    Version of Record online : 6 SEP 2013, DOI: 10.1111/j.1538-7836.2005.03000.x

  6. Factor Xa inhibitors for acute coronary syndromes

    Intervention Review

    The Cochrane Library

    Viviana Brito, Agustín Ciapponi and Joey Kwong

    Published Online : 19 JAN 2011, DOI: 10.1002/14651858.CD007038.pub2

  7. You have free access to this content
    Fondaparinux combined with intermittent pneumatic compression vs. intermittent pneumatic compression alone for prevention of venous thromboembolism after abdominal surgery: a randomized, double-blind comparison

    Journal of Thrombosis and Haemostasis

    Volume 5, Issue 9, September 2007, Pages: 1854–1861, A. G. G. TURPIE, K. A. BAUER, J. A. CAPRINI, P. C. COMP, M. GENT, J. E. MUNTZ and ON BEHALF OF THE APOLLO INVESTIGATORS

    Version of Record online : 15 JUN 2007, DOI: 10.1111/j.1538-7836.2007.02657.x

  8. You have free access to this content
    Recombinant factor VIIa reverses the in vitro and ex vivo anticoagulant and profibrinolytic effects of fondaparinux

    Journal of Thrombosis and Haemostasis

    Volume 1, Issue 11, November 2003, Pages: 2368–2373, T. Lisman, N. R. Bijsterveld, J. Adelmeijer, J. C. M. Meijers, M. Levi, H. K. Nieuwenhuis and P. G. De Groot

    Version of Record online : 18 NOV 2003, DOI: 10.1046/j.1538-7836.2003.00536.x

  9. Anticoagulation With Fondaparinux for Hemodiafiltration in Patients With Heparin-Induced Thrombocytopenia: Dose-Finding Study and Safety Evaluation

    Artificial Organs

    Volume 37, Issue 5, May 2013, Pages: 482–487, Elien Mahieu, Kathleen Claes, Marc Jacquemin, Pieter Evenepoel, Karel Op De Beek, Anne-Marie Bogaert, Dirk Kuypers, Peter Verhamme and Björn Meijers

    Version of Record online : 5 MAR 2013, DOI: 10.1111/aor.12002

  10. You have free access to this content
    The synthetic pentasaccharide fondaparinux reduces coagulation, inflammation and neutrophil accumulation in kidney ischemia–reperfusion injury

    Journal of Thrombosis and Haemostasis

    Volume 3, Issue 3, March 2005, Pages: 531–540, R. D. FRANK, G. SCHABBAUER, T. HOLSCHER, Y. SATO, M. TENCATI, R. PAWLINSKI and N. MACKMAN

    Version of Record online : 4 MAR 2005, DOI: 10.1111/j.1538-7836.2005.01188.x

  11. You have free access to this content
    Comparison of the anticoagulant intensities of fondaparinux and enoxaparin in the organization to assess strategies in acute ischemic syndromes (OASIS)-5 trial

    Journal of Thrombosis and Haemostasis

    Volume 8, Issue 2, February 2010, Pages: 243–249, J. A. M. ANDERSON, J. HIRSH, S. YUSUF, M. JOHNSTON, R. AFZAL, S. R. MEHTA, K. A. A. FOX, A. BUDAJ and J. W. EIKELBOOM

    Version of Record online : 26 NOV 2009, DOI: 10.1111/j.1538-7836.2009.03705.x

  12. Assessment of an Extended Interval Fondaparinux Dosing Regimen for Venous Thromboembolism Prophylaxis in Critically Ill Patients with Severe Renal Dysfunction Using Antifactor Xa Levels

    Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy

    Accepted manuscript online: 22 AUG 2017, Krista A. Wahby, Lauren K. Riley and Steven D. Tennenberg

    DOI: 10.1002/phar.2014

  13. You have free access to this content
    Fondaparinux treatment of acute heparin-induced thrombocytopenia confirmed by the serotonin-release assay: a 30-month, 16-patient case series

    Journal of Thrombosis and Haemostasis

    Volume 9, Issue 12, December 2011, Pages: 2389–2396, T. E. WARKENTIN, M. PAI, J. I. SHEPPARD, S. SCHULMAN, A. C. SPYROPOULOS and J. W. EIKELBOOM

    Version of Record online : 1 DEC 2011, DOI: 10.1111/j.1538-7836.2011.04487.x

  14. You have free access to this content
    Fondaparinux, a Synthetic Pentasaccharide: The First in a New Class of Antithrombotic Agents — The Selective Factor Xa Inhibitors

    Cardiovascular Drug Reviews

    Volume 20, Issue 1, March 2002, Pages: 37–52, Kenneth A. Bauer, David W. Hawkins, Paul C. Peters, Maurice Petitou, Jean-Marc Herbert, Constant A. A. van Boeckel and Dirk G. Meuleman

    Version of Record online : 7 JUN 2006, DOI: 10.1111/j.1527-3466.2002.tb00081.x

  15. FondaKIDS: A prospective pharmacokinetic and safety study of fondaparinux in children between 1 and 18 years of age

    Pediatric Blood & Cancer

    Volume 57, Issue 6, 1 December 2011, Pages: 1049–1054, Guy Young, Donald L. Yee, Sarah H. O'Brien, Rachna Khanna, April Barbour and Diane J. Nugent

    Version of Record online : 11 FEB 2011, DOI: 10.1002/pbc.23011

  16. You have free access to this content
    Abstract

    Journal of Thrombosis and Haemostasis

    Volume 1, Issue S1, July 2003, Pages: P2016–P2083a,

    Version of Record online : 7 MAR 2014, DOI: 10.1111/j.1538-7836.2003.tb00129.x

  17. Emerging Options for Thromboprophylaxis After Orthopedic Surgery: A Review of Clinical Data

    Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy

    Volume 24, Issue 7P2, July 2004, Pages: 66S–72S, Bob L. Lobo

    Version of Record online : 16 JAN 2012, DOI: 10.1592/phco.24.10.66S.36117

  18. Fondaparinux vs. enoxaparin in patients with non-ST elevation acute coronary syndromes (NSTE-ACS) treated with percutaneous coronary intervention and tirofiban: an exploratory study in China

    Journal of Clinical Pharmacy and Therapeutics

    Volume 40, Issue 5, October 2015, Pages: 584–589, X. M. Zhao, C. Y. Gao, Y. J. Chu, L. Yang, X. Z. Yang, W. K. Xu, W. Q. He, P. R. Zhang, X. Y. Liu and L. X. Tian

    Version of Record online : 6 AUG 2015, DOI: 10.1111/jcpt.12315

  19. You have free access to this content
    The cost-effectiveness of fondaparinux compared with enoxaparin as prophylaxis against thromboembolism following major orthopedic surgery

    Journal of Thrombosis and Haemostasis

    Volume 1, Issue 10, October 2003, Pages: 2167–2174, A. Gordois, J. Posnett, L. Borris, P. Bossuyt, B. Jönsson, E. Levy and G. De Pouvourville

    Version of Record online : 22 JUL 2003, DOI: 10.1046/j.1538-7836.2003.00396.x

  20. You have free access to this content
    Efficacy and safety of rivaroxaban or fondaparinux thromboprophylaxis in major orthopedic surgery: findings from the ORTHO-TEP registry

    Journal of Thrombosis and Haemostasis

    Volume 10, Issue 10, October 2012, Pages: 2045–2052, J. BEYER-WESTENDORF, J. LÜTZNER, L. DONATH, O. C. RADKE, E. KUHLISCH, A. HARTMANN, N. WEISS and S. WERTH

    Version of Record online : 1 OCT 2012, DOI: 10.1111/j.1538-7836.2012.04877.x